Shares of Houlihan Lokey cratered to $115.20 today — a stunning 17.2% single-session plunge — as a brutal post-earnings selloff entered its second day. The investment bank missed Wall Street's revenue expectations, with sales falling 15.6% year on year to $511 million. At today's price, HLI has been nearly cut in half from its 52-week high of $211.78 , raising serious questions about whether the firm's deal-driven business model can hold up in a world where clients are freezing transactions.

  • The Revenue Miss Was Far Bigger Than Anyone Expected. Revenue came in at $511 million versus analyst estimates of $610.3 million — a 16.3% miss — while adjusted earnings of $1.35 per share fell 17.7% below the $1.64 consensus.

Net income fell to $78 million ($1.15 per share) from $98 million ($1.42) a year ago, and adjusted net income dropped to $91 million from $148 million. That kind of double-digit miss signals that deals are not just delayed — they are evaporating from the near-term pipeline.

  • Geopolitics and a Frozen Tech Sector Are Killing the Core Business. CEO Scott Adelson attributed the shortfall to specific headwinds: "instability in the Middle East and disruptions in the technology sector, specifically in software."

The contrast between the July investor presentation's historical strength and the Q1 reality underscores the challenges facing middle-market advisory firms as macroeconomic and geopolitical uncertainty delays deal closings. When technology companies — historically Houlihan's richest fee source — stop merging, it hits revenue fast because advisory fees are only earned when a deal closes.

  • Management Says It's Temporary, but the Numbers Say Two Quarters and Counting. Management characterized the quarter as "a temporary disruption rather than a fundamental change in its outlook." Yet the prior quarter also missed, with adjusted EPS of $1.63 versus $1.79 expected and revenue of $636 million versus $686.3 million forecast. Two consecutive misses make "temporary" a harder sell, especially when five analysts have recently revised earnings downward.

  • The Stock Now Sits Far Below Where Wall Street Says It Should. Heading into earnings, the average analyst price target sat at $169.75. At $115.20, HLI trades at a 32% discount to that target — either a screaming value opportunity or a sign the Street hasn't finished cutting estimates. The firm held its adjusted compensation expense ratio at 61.5% despite the revenue miss , meaning it hasn't cut headcount, a bet that deal flow rebounds. If it doesn't, margins will compress, and further downside is likely.